Preclinical News and Research

RSS
Idera Pharmaceuticals' preclinical data on novel GSO technology presented at TIDES 2011

Idera Pharmaceuticals' preclinical data on novel GSO technology presented at TIDES 2011

Galectin-3 research uncovers new use for Modified Citrus Pectin in cardiovascular, heart disease

Galectin-3 research uncovers new use for Modified Citrus Pectin in cardiovascular, heart disease

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

Practical solutions for translational science from Randox Laboratories

Practical solutions for translational science from Randox Laboratories

Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011

Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011

Pieris' PRS-080 preclinical data in anemia presented at International BioIron Society Meeting

Pieris' PRS-080 preclinical data in anemia presented at International BioIron Society Meeting

New data from ProSavin Phase I/II trial in Parkinson's presented at ASGCT annual meeting

New data from ProSavin Phase I/II trial in Parkinson's presented at ASGCT annual meeting

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

PolyMedix's PMX-30063 compound mitigates ulcerative mucositis in pre-clinical studies

PolyMedix's PMX-30063 compound mitigates ulcerative mucositis in pre-clinical studies

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

ShangPharma first quarter net revenues increase 25.6% to $24.8 million

ShangPharma first quarter net revenues increase 25.6% to $24.8 million

AVAC calls on donors, policy makers to strengthen support for AIDS vaccine research

AVAC calls on donors, policy makers to strengthen support for AIDS vaccine research

Humanized BLT mice help prevent HIV/AIDS transmission

Humanized BLT mice help prevent HIV/AIDS transmission

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Synergy expands GC-C agonist technology to lower cholesterol

Synergy expands GC-C agonist technology to lower cholesterol

Pharma Two B plans to initiate P2B001 Phase II study in Parkinson's disease

Pharma Two B plans to initiate P2B001 Phase II study in Parkinson's disease

Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis

Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis

Anavex comments on new Alzheimer’s disease diagnostic guidelines

Anavex comments on new Alzheimer’s disease diagnostic guidelines

Excaliber subsidiary merges with VistaGen

Excaliber subsidiary merges with VistaGen

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.